Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.17 +0.00 (+0.01%)
As of: Sep 30, 2026 · 9:35 AM EDT

Telomir Pharmaceuticals (TELO) Retained Earnings (2022 - 2026)

Updated

Telomir Pharmaceuticals' Retained Earnings was -$43.72 million in Q2 2026, compared with -$37.85 million a year earlier.

Analysis

Telomir Pharmaceuticals (TELO) Retained Earnings (2022 - 2026) Analysis & Trends

At the end of FY2025, Retained Earnings at Telomir Pharmaceuticals came in at -$41.01 million.

  • In earlier years, Retained Earnings was -$30.6 million in FY2024, -$14.06 million in FY2023 and -$992,278 in FY2022.
  • The Q2 2026 figure marks the lowest quarterly Retained Earnings in data going back to Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 171.67 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -17.33 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 63.27 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 40.86 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 12.59 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -22.28 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 2.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 112.09 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 15.69 Bn
10 Telomir Pharmaceuticals 82.53 Mn 82.53 Mn - -43.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -43.72 Mn
Dec 31, 2025 -41.01 Mn
Sep 30, 2025 -38.95 Mn
Jun 30, 2025 -37.85 Mn
Mar 31, 2025 -32.78 Mn
Dec 31, 2024 -30.60 Mn
Sep 30, 2024 -27.70 Mn
Jun 30, 2024 -21.77 Mn
Mar 31, 2024 -20.32 Mn
Dec 31, 2023 -14.06 Mn
Dec 31, 2022 -992,278.00
API Access

Telomir Pharmaceuticals Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=TELO&period=max&api_key=YOUR_API_KEY